openPR Logo
Press release

Rodenticides Market Revenues to Gain $6.6 billion by 2026

02-22-2021 07:50 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: Markets and Market

The global rodenticides market size is estimated to be valued at USD 4.9 billion in 2020 and is expected to reach a value of USD 6.6 billion by 2026, growing at a CAGR of 5.0% during the forecast period. Factors such as the displacement of rodents due to urbanization and increase in rodent population due to climatic change such as global warming drive the growth of the market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=189089498

The rodenticides market includes major product manufacturers and service providers like Syngenta AG, Bayer AG, BASF SE, UPL Ltd, Rentokil Initial plc, Ecolab Inc and Rollins Inc. These companies have their manufacturing and service facilities spread across various countries across Asia Pacific, Europe, North America, South America, and RoW. COVID-19 has impacted their businesses up to some extent. Though this pandemic situation has impacted their businesses, there is no significant impact on the global operations and supply chain of rodenticides. Multiple manufacturing facilities of players are still in operation. The service providers are providing rodent control services by following safety and sanitation measures.

Anticoagulant, by type, is estimated to grow at the highest rate during the forecast period

Anticoagulant rodenticides are widely used for controlling commensal rodents, which are primarily Norway rats, ship rats, and house mice. Despite the consistent decrease in ecological risk assessments, the anticoagulant segment is projected to dominate the rodenticides market due to the high demand for effective rodent-control alternatives and the lack of safe alternatives.

Pellet, by mode of application is estimated to hold the largest share in the rodenticides market, in terms of value, in 2020

Pellets offer effective control against commensal rodents and are resistant to various environmental conditions, which makes them suitable for outdoor use. With the increase in urbanization and displacement of rats in city areas, the pellets mode of application is widely used in residential buildings, as they can easily be used with baits.

Commercial, by end-use sector, estimated to account for the largest market share, by value, in 2020

A majority of the commercial places across the European and North American countries have a mandate annual rodent control service program. Hence, the market is estimated to be dominated by the commercial segment in 2020.

Make an Inquiry: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=189089498

Asia Pacific is projected to grow at the highest CAGR during the forecast period

The market for rodenticides is projected to grow at the highest CAGR in the Asia Pacific region owing to the increase in awareness of the effectivity of chemical rodenticides. As the world’s largest and most populous region, Asia Pacific is one of the key markets for rodenticides. Rodents are common pests present in agricultural fields. Annually, extensive volumes of agricultural produce are destroyed and contaminated by rodents. To meet the increase in demand for food products and to reduce the crop damages caused by rodents, the use of rodenticides has increased significantly in the region. Food retail, food manufacturing, pharmaceutical, hospitality, and residential sectors are projected to be major growth verticals in this market.

Key players are Bayer AG (Germany), Syngenta AG (Switzerland), BASF SE (Germany), Rentokil Initial Plc (UK), Ecolab Inc (US), Rollins Inc (US), UPL Limited (India), Anticimex (Sweden), The Terminix International Company (US), Liphatech Inc (US), Neogen Corporation (US), PelGar International (UK), Bell Laboratories Inc (US), JT Eaton (US), Truly Nolen (US), Abell Pest Control (Canada), Futura Germany (Germany), SenesTech Inc (US), Bioguard Pest Solutions (US) and Impex Europa S.L (Spain).

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Rodenticides Market Revenues to Gain $6.6 billion by 2026 here

News-ID: 2246066 • Views:

More Releases from Markets and Market

Cloud Managed Services Market Size, Share, Industry Trend, Revenue, Growth Rate Analysis Report - 2026
Cloud Managed Services Market Size, Share, Industry Trend, Revenue, Growth Rate …
The Cloud Managed Services Market Size is expected to grow from USD 86.1 billion in 2021 to USD 139.4 billion by 2026, at a Compound Annual Growth Rate (CAGR) of 10.1% during the forecast period. Cloud managed services, such as mobility services, security services, and data services, are provided to the organizations by MSPs for handling their various business activities. Hence, cloud managed services would ensure organizations are not much
Learning Management System (LMS) Market Size, Trend, Historical Analysis, Current Industry Scenario 2026
Learning Management System (LMS) Market Size, Trend, Historical Analysis, Curren …
Global Learning Management System (LMS) Market size to grow from USD 15.8 billion in 2021 to USD 37.9 billion by 2026, at a Compound Annual Growth Rate (CAGR) of 19.1% during the forecast period. The LMS Market is fuelled by enterprises focusing more on human capital development. Effective employee learning and development brings a positive impact on employee performance and organizational competitiveness. Training also helps employees develop a positive attitude

More Releases for MarketsandMarkets™

Biomaterials Market Worth $64.2 billion | MarketsandMarkets™
Biomaterials Market in terms of revenue was estimated to be worth $45.2 billion in 2024 and is poised to reach $64.2 billion by 2029, growing at a CAGR of 7.3% from 2024 to 2029 according to a new report by MarketsandMarkets™. The biomaterials market is estimated to grow at a CAGR of 7.3% during the forecast period of 2024 to 2029. The important factors impacting market growth are the growing
Cell Expansion Market Worth $26.7 billion | MarketsandMarkets™
Cell Expansion Market in terms of revenue was estimated to be worth $14.3 billion in 2024 and is poised to reach $26.7 billion by 2029, growing at a CAGR of 13.3% from 2024 to 2029 according to a new report by MarketsandMarkets™. Some factors contributing to the growth of the global market includes increasing R&D investments in cell based research, growing focus on personalized medicine, and increasing number of strategic
Apheresis Market Worth $3.9 billion | MarketsandMarkets™
Apheresis Market in terms of revenue was estimated to be worth $2.6 billion in 2024 and is poised to reach $3.9 billion by 2029, growing at a CAGR of 8.8% from 2024 to 2029 according to a new report by MarketsandMarkets™. The growth in the apheresis market is driven by rise in demand for source plasma from biopharmaceutical companies, upsurging demand for blood components and favourable reimbursement for apheresis. The increasing
Medical Robots Market Worth $33.8 billion | MarketsandMarkets™
Medical Robots Market in terms of revenue was estimated to be worth $16.0 billion in 2024 and is poised to reach $33.8 billion by 2029, growing at a CAGR of 16.1% from 2024 to 2029 according to a new report by MarketsandMarkets™. The growth in the medical robots market is driven by the aging population and rising chronic diseases, improving reimbursement scenario, and subsequent advancements in healthcare funding & infrastructure.
Pipette Calibrators Market Worth $391 million | MarketsandMarkets™
Pipette Calibrators Market in terms of revenue was estimated to be worth $286 million in 2024 and is poised to reach $391 million by 2029, growing at a CAGR of 6.5% from 2024 to 2029 according to a new report by MarketsandMarkets™. The growth of this market is majorly driven by rise in genomics and proteomics research, growth in portable and handheld devices, and establishment of new research facilities by pharmaceutical
Mice Model Market Worth $2.2 billion | MarketsandMarkets™
Mice Model Market in terms of revenue was estimated to be worth $1.5 billion in 2024 and is poised to reach $2.2 billion by 2029, growing at a CAGR of 8.1% from 2024 to 2029 according to a new report by MarketsandMarkets™. The rise in chronic diseases, such as cancer, diabetes, and cardiovascular disorders, and growing need for reliable and predictive animal models to facilitate drug discovery and development are